Primary refractory Hodgkin lymphoma: limited options and poor survival--but not always

Am J Hematol. 2014 Aug;89(8):853-7. doi: 10.1002/ajh.23660. Epub 2014 Apr 10.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols*
  • Biopsy
  • Bleomycin / administration & dosage
  • Brentuximab Vedotin
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / immunology
  • Hodgkin Disease / pathology
  • Humans
  • Immunoconjugates / therapeutic use*
  • Lymph Nodes / drug effects
  • Lymph Nodes / immunology
  • Lymph Nodes / pathology
  • Salvage Therapy*
  • Treatment Outcome
  • Vinblastine / administration & dosage

Substances

  • Immunoconjugates
  • Bleomycin
  • Vinblastine
  • Dacarbazine
  • Brentuximab Vedotin
  • Doxorubicin